Mitchell et al. demonstrate that genetic or pharmacological inhibition (HCQ) of autophagy sensitizes ponatinib-resistant CML cells to death induced by mTOR inhibition in vitro and in vivo. The gene discussed is MTOR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.